日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies

简化癌症临床试验流程：美国国家癌症研究所后期临床研究的新标准数据收集规范

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djae239
Prindiville, Sheila A; Mandrekar, Sumithra J; Meropol, Neal J; Denicoff, Andrea; Grad, Oren; Hautala, Judith A; Doroshow, James H
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Re-Envisioning Electronic Health Records to Optimize Patient-Centered Cancer Care, Quality, Surveillance, and Research

重新构想电子健康记录，以优化以患者为中心的癌症护理、质量、监测和研究

期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP.24.00260
Singh, Aditi P; Balogh, Erin P; Carlson, Robert W; Huizinga, Mary Margaret; Malin, Bradley A; Melamed, Alexander; Meropol, Neal J; Pisano, Etta D; Winn, Robert A; Yabroff, K Robin; Shulman, Lawrence N
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201

一项针对 II/III 期直肠癌的辅助治疗方案（FOLFIRI、FOLFOX 或 5-FU/亚叶酸钙）的多中心随机 III 期研究：ECOG-ACRIN E3201

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf416
Kam, Audrey E; Zhao, Fengmin; Meropol, Neal J; Giantonio, Bruce J; Diasio, Robert B; Flynn, Patrick J; Catalano, Paul; Hartner, Lee; Rowland, Kendrith M; Song, Wei; Mulcahy, Mary F; Sinicrope, Frank A; Whitehead, Robert P; Mayer, Robert J; Petrelli, Nicholas; O'Dwyer, Peter J; Hamilton, Stanley R; Cella, David; Benson, Al B
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

The National Institutes of Health COVID-19 Neuro Databank/Biobank: Creation and Evolution

美国国立卫生研究院 COVID-19 神经数据库/生物样本库：创建与演变

期刊:Neuroepidemiology
影响因子:4
doi:10.1159/000539830
Meropol, Sharon B; Norris, Cecile J; Frontera, Jennifer A; Adeagbo, Adenike; Troxel, Andrea B
发表日期：2025
文献求助 收藏

Building community through data: the value of a researcher driven open science ecosystem

通过数据构建社群：研究者驱动的开放科学生态系统的价值

期刊:Pain Medicine
影响因子:3
doi:10.1093/pm/pnaf003
Adams, Meredith C B; Bann, Carla M; Bayman, Emine Ozgur; Chao, Maria; Hergenroeder, Georgene W; Knott, Charles; Lindquist, Martin A; Luo, Z David; Martin, Rosemarie; Martone, Maryann E; McCarthy, John; McCumber, Micah; Meropol, Sharon B; Ridenour, Ty A; Saavedra, Lissette M; Sarker, Abeed; Anstrom, Kevin J; Thompson, Wesley K
发表日期：2025
文献求助 收藏

Real-world enrollment for a prospective clinico-genomic database using a pragmatic technology-enabled platform

利用务实的技术平台，在真实世界中招募参与者建立前瞻性临床基因组数据库。

期刊:Contemporary Clinical Trials Communications
影响因子:1.4
doi:10.1016/j.conctc.2025.101446
Exarchos, Alexia; Bourla, Ariel B; Kaur, Maneet; Schulze, Katja; Maund, Sophia; Cao, Yi; Zhao, Yihua; Williams, Elizabeth H; Gaffey, Sarah C; Zuniga, Richard; Lakhanpal, Shaily; Antic, Vladan; Doral, Michelle; Sy, Johanna; Meropol, Neal J; Chiang, Anne C
发表日期：2025
文献求助 收藏

Analysis of the National Institutes of Health COVID-19 Neuro Databank by geographic region and income status

按地理区域和收入状况分析美国国立卫生研究院 COVID-19 神经数据库

期刊:
影响因子:
doi:10.21203/rs.3.rs-7371770/v1
Dominguez, Jacqueline C; Fowler, Krizelle Cleo; Koralnik, Igor J; Liow, Kore; Ampil, Encarnita; Zhi, Qi; Laxamana, Lina; Berroya, Remy; Noris, Cecile J; Meropol, Sharon B; Troxel, Andrea B
发表日期：2025
文献求助 收藏

Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics

设有临床研究项目的社区肿瘤诊疗机构与未设有临床研究项目的社区肿瘤诊疗机构有何不同？患者和诊疗机构特征的比较

期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkae060
Altomare, Ivy; Wang, Xiaoliang; Kaur, Maneet; Guadamuz, Jenny S; Falk, Sam; Xiao, Forrest; Meropol, Neal J; Zhao, Yihua
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗（有或无贝伐珠单抗）的随机 III 期双盲安慰剂对照试验：ECOG-ACRIN 癌症研究组 (E1105) 的一项试验

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07417-4
Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗（有或无贝伐珠单抗）的随机 III 期双盲安慰剂对照试验：ECOG-ACRIN 癌症研究组的一项试验 (E1105)

期刊:
影响因子:
doi:10.21203/rs.3.rs-4295044/v1
Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏